Award recordCONTRACT

ALBA BIOSCIENCE, INC.

PIID 36C26122F0032· VHA· 261-NETWORK CONTRACT OFFICE 21 (36C261)· 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS· FY2022· $76,729 net obligations· UEI V6KNKL6BDHL7· IL

Description

BLOOD TUBE TESTING REAGENTS DEOB

Base award description: BLOOD TUBE TESTING REAGENTS

First action · last action
2021-10-01 · 2026-02-12
Transactions
11
First transaction's obligation
$21,270
Base + all options value (sum of deltas)
$98,000
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
3
SDVOSB flag on record
No
Parent IDV
36F79721D0259
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING

Modification chain · 11 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$85,248$0Base award · 2021-10-01 · this action $21,270 · running total $21,270Modification P00001 · 2022-10-01 · this action $21,270 · running total $42,541Modification P00002 · 2023-03-19 · this action -$8,358 · running total $34,183Modification P00003 · 2023-10-01 · this action $21,270 · running total $55,453Modification P00004 · 2024-01-27 · this action -$7,792 · running total $47,661Modification P00005 · 2024-06-25 · this action $0 · running total $47,661Modification P00006 · 2024-10-01 · this action $21,270 · running total $68,931Modification P00007 · 2024-12-10 · this action -$9,187 · running total $59,744Modification P00008 · 2025-01-27 · this action $1,903 · running total $61,647Modification P00009 · 2025-10-01 · this action $23,601 · running total $85,248Modification P00010 · 2026-02-12 · this action -$8,519 · running total $76,729
  • Base2021-10-01+$21,270= $21,270
  • Mod P000012022-10-01+$21,270= $42,541
  • Mod P000022023-03-19-$8,358= $34,183
  • Mod P000032023-10-01+$21,270= $55,453
  • Mod P000042024-01-27-$7,792= $47,661
  • Mod P000052024-06-25+$0= $47,661
  • Mod P000062024-10-01+$21,270= $68,931
  • Mod P000072024-12-10-$9,187= $59,744
  • Mod P000082025-01-27+$1,903= $61,647
  • Mod P000092025-10-01+$23,601= $85,248
  • Mod P000102026-02-12-$8,519= $76,729
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2021-10-01+$21,270$21,270BLOOD TUBE TESTING REAGENTS
Mod P00001· EXERCISE AN OPTION2022-10-01+$21,270$42,541BLOOD TUBE TESTING REAGENTS
Mod P00002· FUNDING ONLY ACTION2023-03-19−$8,358$34,183BLOOD TUBE TESTING REAGENTS
Mod P00003· EXERCISE AN OPTION2023-10-01+$21,270$55,453BLOOD TUBE TESTING REAGENTS OY2
Mod P00004· FUNDING ONLY ACTION2024-01-27−$7,792$47,661BLOOD TUBE TESTING REAGENTS OY2
Mod P00005· OTHER ADMINISTRATIVE ACTION2024-06-25+$0$47,661BLOOD TUBE TESTING REAGENTS ADMIN MOD
Mod P00006· EXERCISE AN OPTION2024-10-01+$21,270$68,931BLOOD TUBE TESTING REAGENTS OY3
Mod P00007· FUNDING ONLY ACTION2024-12-10−$9,187$59,744BLOOD TUBE TESTING REAGENTS OY3
Mod P00008· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2025-01-27+$1,903$61,647BLOOD TUBE TESTING REAGENTS INCREASE
Mod P00009· EXERCISE AN OPTION2025-10-01+$23,601$85,248BLOOD TUBE TESTING REAGENTS OY4
Mod P00010· FUNDING ONLY ACTION2026-02-12−$8,519$76,729BLOOD TUBE TESTING REAGENTS DEOB

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI V6KNKL6BDHL7)

AwardOffice · PSC / listingNet obligationsFY
36C25526N0306255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$40,949FY2026
36C25926N0280NETWORK CONTRACT OFFICE 19 (36C259) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$64,078FY2026
36C25726N0176257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS$7,634FY2026
36C25726N0224257-NETWORK CONTRACT OFFICE 17 (36C257) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$16,514FY2026
36C25626N0214256-NETWORK CONTRACT OFFICE 16 (36C256) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$23,127FY2026
36C25026N0043250-NETWORK CONTRACT OFFICE 10 (36C250) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS$21,884FY2026

Other recipients under 6550 from 261-NETWORK CONTRACT OFFICE 21 (36C261) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26126N0364BIOMERIEUX INC261-NETWORK CONTRACT OFFICE 21 (36C261)$112,848FY2026
36C26126N0371RLS (USA) INC.261-NETWORK CONTRACT OFFICE 21 (36C261)$250,075FY2026
36C26126P0448ROCHE DIAGNOSTICS CORPORATION261-NETWORK CONTRACT OFFICE 21 (36C261)$120,976FY2026
36C26126F0102WERFEN USA LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$79,671FY2026
36C26126P0353HEMOSONICS, LLC261-NETWORK CONTRACT OFFICE 21 (36C261)$82,300FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C26122F0032_3600_36F79721D0259_3600 · retrieved 2026-09-26.